SMMT Financials

Summit Therapeutics PLC - Financial statements & key metrics

Stock Price

$14.16

Market Cap

$11.46B

P/E Ratio

-45.7

EPS

$-0.31

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-221.31M

EPS (Diluted)

$-0.31

Balance Sheet Highlights

Total Assets

$435.56M

Total Liabilities

$46.81M

Shareholders Equity

Cash & Equivalents

$104.86M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-142.11M

CapEx

Free Cash Flow

Profitability Metrics

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is SMMT revenue?

View SMMT's income statement for detailed revenue data.

Is SMMT profitable?

SMMT reported a loss of $221.31M in the most recent quarter.

What is SMMT market cap?

SMMT has a market capitalization of $11.46B, making it a large-cap stock.

Does SMMT have debt?

View SMMT's balance sheet for debt information.

What is SMMT cash flow?

Cash flow data is available in the full financial statements.